# Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

> **NCT02938494** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 210 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** IDP-123 Lotion
- **DRUG:** Tazorac Cream
- **DRUG:** Vehicle Lotion
- **DRUG:** Vehicle Cream

## Key facts

- **NCT ID:** NCT02938494
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2020-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02938494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02938494, "Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02938494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*